Vimarsana
Biggest News Aggregation in the World

Block Coronavirus News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Block Coronavirus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Block Coronavirus Today - Breaking & Trending Today

PharmaDrug Inc.: PharmaDrug Successfully Completes Key Milestone to Support cGMP Production of Clinical Lead Candidate PD-001, Its Patented, Orally Available Version of Cepharanthine for Oncology and Infectious Disease - Vimarsana News

PharmaDrug Inc.: PharmaDrug Successfully Completes Key Milestone to Support cGMP Production of Clinical Lead Candidate PD-001, Its Patented, Orally Available Version of Cepharanthine for Oncology and Infectious Disease

Published: August 19, 2022

Completes qualification of all necessary analytical methodologies to support production of Cepharanthine-2HCL drug substanceClinical trial-scale production of cGMP Cepharanthine-2HCL drug substance scheduled

Source: finanznachrichten.de
Related Topics:
United StatesSouth AfricaJapan GeneralSouth AfricanWangy CepharanthineDaniel CohenBaillyc CepharanthineNewsfile CorpDevelopment Paths For OncologyPharmadrug IncDrug AdministrationGenvion CorporationDevelopment PathsInfectious Disease CreateEnteric Coated Oral CepharanthineValidated Studies Reveal PotentialEnabling Prostate CancerEnabling Esophageal CancerDrug DesignationInfectious DiseaseMiddle EastCepharanthine May WorkBlock CoronavirusSairiyo TherapeuticsSuper Smart
Pharmadrug Inc.: Pharmadrug Announces Successful Completion of Pre-IND Meeting with FDA Regarding Proposed Development of Its Cepharanthine for Treatment of Mild to Moderate COVID-19 Infection - Vimarsana News

Pharmadrug Inc.: Pharmadrug Announces Successful Completion of Pre-IND Meeting with FDA Regarding Proposed Development of Its Cepharanthine for Treatment of Mild to Moderate COVID-19 Infection

Published: November 30, 2021

Established alignment with FDA on the path forward for the development of PD-001, a patented enteric-coated formulation of cepharanthine, towards clinical studies for mild-moderate COVID-19 infectionMeeting

Source: finanznachrichten.de
Related Topics:
United StatesSouth AfricaJapan GeneralBaden WübergSouth AfricanDaniel CohenVan SlykeBaillyc CepharanthineNewsfile CorpSchedulei European UnionPharmadrug IncEuropean UnionDrug AdministrationBreakthrough DesignationManufacturing ControlChief Scientific OfficerMiddle EastCepharanthine May WorkBlock CoronavirusEnteric Coated CepharanthinePharmadrug Production GmbhSairiyo TherapeuticsSuper SmartRegarding Forward Looking InformationDrug Repurposing Screens